camptothecin has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Li, P; Pang, T; Qi, LW; Shi, ZQ; Wang, J; Xin, GZ; Xu, X; Yang, H; Zhang, M; Zhou, P | 1 |
1 other study(ies) available for camptothecin and amyloid beta-peptides
Article | Year |
---|---|
Camptothecin and its analogs reduce amyloid-β production and amyloid-β42-induced IL-1β production.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Camptothecin; Caspases; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Gene Expression Regulation; HEK293 Cells; Humans; Inhibitory Concentration 50; Interleukin-1beta; Mass Spectrometry; Mutation; Neuroblastoma; Peptide Fragments; Transfection | 2015 |